Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin's lymphoma receiving combination chemotherapy

Anders Österborg, Juan Luis Steegmann, Andrzej Hellmann, Stephen Couban, Jiri Mayer, Joseph E. Eid

科研成果: 期刊稿件文章同行评审

15 引用 (Scopus)

指纹

探究 'Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin's lymphoma receiving combination chemotherapy' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science